The healthcare community is excited about the new drug, a dual-action therapy showing significant benefits in clinical trials . This groundbreaking compound, a incretin receptor alongside a similar compound, appears to substantially decrease body size and enhance metabolic health . Clinicians are indicating that it could offer a significant adva… Read More